Compare OCGN & STKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCGN | STKL |
|---|---|---|
| Founded | 2013 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.3M | 454.0M |
| IPO Year | N/A | N/A |
| Metric | OCGN | STKL |
|---|---|---|
| Price | $1.60 | $4.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $7.00 | ★ $7.75 |
| AVG Volume (30 Days) | ★ 6.2M | 1.1M |
| Earning Date | 03-04-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $5,370,000.00 | ★ $792,436,000.00 |
| Revenue This Year | $35.88 | $13.49 |
| Revenue Next Year | N/A | $7.13 |
| P/E Ratio | ★ N/A | $110.28 |
| Revenue Growth | ★ 14.26 | 11.95 |
| 52 Week Low | $0.52 | $3.32 |
| 52 Week High | $1.96 | $7.68 |
| Indicator | OCGN | STKL |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 66.81 |
| Support Level | $1.57 | $3.60 |
| Resistance Level | $1.70 | $5.01 |
| Average True Range (ATR) | 0.14 | 0.22 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 22.45 | 79.08 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.